Literature DB >> 17099087

Testing for thrombophilia: an evidence-based approach.

L Merriman1, M Greaves.   

Abstract

Thrombophilia is a disorder of haemostasis in which there is a tendency for the occurrence of thrombosis. This tendency can be inherited or acquired. This review outlines common acquired and inherited thrombophilic conditions and discusses indications for testing. It is concluded that testing for acquired thrombophilic conditions should be considered in all cases of venous thrombosis, whereas testing for inherited thrombophilic conditions is unlikely to be helpful. If testing for inherited thrombophilia is to be carried out, the benefits, pitfalls and unwanted consequences of such testing should be taken into account.

Entities:  

Mesh:

Year:  2006        PMID: 17099087      PMCID: PMC2660493          DOI: 10.1136/pgmj.2006.048090

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  42 in total

1.  Investigation and management of heritable thrombophilia.

Authors: 
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

2.  Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

Authors:  E Høibraaten; E Qvigstad; H Arnesen; S Larsen; E Wickstrøm; P M Sandset
Journal:  Thromb Haemost       Date:  2000-12       Impact factor: 5.249

3.  The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Authors:  Sabine Eichinger; Ansgar Weltermann; Christine Mannhalter; Erich Minar; Christine Bialonczyk; Mirko Hirschl; Verena Schönauer; Klaus Lechner; Paul A Kyrle
Journal:  Arch Intern Med       Date:  2002-11-11

4.  Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.

Authors:  F R Rosendaal; M Vessey; A Rumley; E Daly; M Woodward; F M Helmerhorst; G D O Lowe
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

5.  Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden.

Authors:  I Pabinger; L Nemes; C Rintelen; S Koder; E Lechler; R M Loreth; P A Kyrle; I Scharrer; G Sas; K Lechner; C Mannhalter; S Ehrenforth
Journal:  Hematol J       Date:  2000

6.  Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

Authors:  P Brill-Edwards; J S Ginsberg; M Gent; J Hirsh; R Burrows; C Kearon; W Geerts; M Kovacs; J I Weitz; K S Robinson; R Whittom; G Couture
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

7.  The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.

Authors:  V De Stefano; I Martinelli; P M Mannucci; K Paciaroni; E Rossi; P Chiusolo; I Casorelli; G Leone
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

8.  The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

Authors:  S Middeldorp; E J Libourel; K Hamulyák; J Van der Meer; H R Büller
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

9.  Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Authors:  J Emmerich; F R Rosendaal; M Cattaneo; M Margaglione; V De Stefano; T Cumming; V Arruda; A Hillarp; J L Reny
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

10.  Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.

Authors:  I Martinelli; C Legnani; P Bucciarelli; E Grandone; V De Stefano; P M Mannucci
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

View more
  8 in total

Review 1.  Role of thrombophilia testing: con.

Authors:  Scott M Stevens
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

Review 2.  Approach to Thrombophilia in Pregnancy-A Narrative Review.

Authors:  Miruna Samfireag; Cristina Potre; Ovidiu Potre; Raluca Tudor; Teodora Hoinoiu; Andrei Anghel
Journal:  Medicina (Kaunas)       Date:  2022-05-23       Impact factor: 2.948

3.  Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia.

Authors:  Elvira D'Andrea; Tyra Lagerberg; Corrado De Vito; Erica Pitini; Carolina Marzuillo; Azzurra Massimi; Maria Rosaria Vacchio; Paola Grammatico; Paolo Villari
Journal:  Eur J Hum Genet       Date:  2018-01-26       Impact factor: 4.246

4.  Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory.

Authors:  Brian R Jackson; Kyland Holmes; Amit Phansalkar; George M Rodgers
Journal:  BMC Clin Pathol       Date:  2008-04-02

Review 5.  Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.

Authors:  Scott M Stevens; Scott C Woller; Kenneth A Bauer; Raj Kasthuri; Mary Cushman; Michael Streiff; Wendy Lim; James D Douketis
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

6.  Hypercoagulable workup in a community hospital setting: to test or not to test; that is the question.

Authors:  Ashish Gupta; Poras Patel; Raheel Anwar; Diana Villanueva; Viswanath Vasudevan; Elizabeth Guevara
Journal:  J Community Hosp Intern Med Perspect       Date:  2019-11-01

7.  Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia.

Authors:  Marloe Prince; Charles J Glueck; Parth Shah; Ashwin Kumar; Michael Goldenberg; Matan Rothschild; Nasim Motayar; Vybhav Jetty; Kevin Lee; Ping Wang
Journal:  BMC Hematol       Date:  2016-03-08

8.  Prevalence and Outcomes of Thrombophilia in Patients with Acute Pulmonary Embolism.

Authors:  Munzir Obaid; Ayman El-Menyar; Mohammad Asim; Hassan Al-Thani
Journal:  Vasc Health Risk Manag       Date:  2020-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.